Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% Halobetasol Propionate) to Ultravate (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis

Next Previous
X
Search
Trial Profile

A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% Halobetasol Propionate) to Ultravate (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Sep 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ulobetasol (Primary) ; Ulobetasol (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Bausch Health Companies; Valeant Pharmaceuticals International

    • Most Recent Events

    • 01 Jun 2019 Results assessing efficacy and safety of halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in moderate-to-severe psoriasis once-daily published in the Journal of Dermatological Treatment
    • 15 Oct 2018 According to a Bausch Health Companies media release, data from this study to Present at The Fall Clinical Dermatology Conference.
    • 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top